COVID-19 and Autoimmune Liver Diseases

SARS-CoV-2 infection can trigger autoimmune responses, either by a systemic hyperstimulation of the immune system or molecular mimicry (or both). We here summarize the current knowledges about autoimmune liver diseases (AILDs) and COVID-19, focusing on (a) the risk of SARS-CoV-2 infection in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Floreani, Annarosa, De Martin, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143939/
https://www.ncbi.nlm.nih.gov/pubmed/35628807
http://dx.doi.org/10.3390/jcm11102681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143939/
https://www.ncbi.nlm.nih.gov/pubmed/35628807
http://dx.doi.org/10.3390/jcm11102681

Ejemplares similares